NAM
MBIO icon

Nexpoint Asset Management’s Mustang Bio MBIO Stock Holding History

Nexpoint Asset Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-113
Closed -$282K – 183
2021
Q1 		$282K Hold
113
– – 0.07% 123
2020
Q4 		$322K Hold
113
– – 0.11% 122
2020
Q3 		$268K Sell
113
-67
-37% -$165K 0.06% 134
2020
Q2 		$429K Buy
180
+20
+13% +$46.8K 0.1% 128
2020
Q1 		$322K Sell
160
-293
-65% -$751K 0.06% 154
2019
Q4 		$1.39M Sell
453
-14
-3% -$32.1K 0.11% 116
2019
Q3 		$1.14M Buy
+467
New +$1.28M 0.07% 189

Other funds holding MBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nexpoint Asset Management's MBIO Position: Q2 2021 in Review

Nexpoint Asset Management sold out of Mustang Bio (MBIO) in Q2 2021, closing a stake of 113 shares — an estimated $282K sold.

Nexpoint Asset Management first reported a position in MBIO in Q3 2019 and held it in 7 quarters. The position peaked at $1.39M in Q4 2019. 92 funds tracked by Wall St. Rank hold MBIO as of Q2 2021.

  • Nexpoint Asset Management reported no remaining Mustang Bio position as of Q2 2021 after selling out during the quarter.
  • Nexpoint Asset Management sold 113 Mustang Bio shares in Q2 2021, an estimated $282K.
  • Nexpoint Asset Management first reported a position in Mustang Bio in Q3 2019 and held it in 7 quarters.
  • Nexpoint Asset Management's Mustang Bio position peaked at $1.39M in Q4 2019.
  • 92 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2021.

Based on Nexpoint Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.